{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T11:08:43Z","timestamp":1783768123021,"version":"3.55.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007957","name":"Chongqing Municipal Education Commission","doi-asserted-by":"publisher","award":["KJQN202500439"],"award-info":[{"award-number":["KJQN202500439"]}],"id":[{"id":"10.13039\/501100007957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Hubei Province Natural Science Foundation","doi-asserted-by":"publisher","award":["2024AFB207"],"award-info":[{"award-number":["2024AFB207"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Hubei Province Natural Science Foundation","doi-asserted-by":"publisher","award":["2024AFB82"],"award-info":[{"award-number":["2024AFB82"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22507040"],"award-info":[{"award-number":["22507040"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.bioorg.2025.109072","type":"journal-article","created":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T14:39:58Z","timestamp":1759675198000},"page":"109072","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Novel dihydropyridines as potential calcium-channel and P-glycoprotein blockers applicable for chemotherapy sensitization"],"prefix":"10.1016","volume":"165","author":[{"given":"Gang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyi","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxu","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Raza","family":"Ishaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanrong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuxin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.109072_bb0005","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0002-9343(02)01049-5","article-title":"Is there an association between hypertension and cancer mortality?","volume":"112","author":"Grossman","year":"2002","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bioorg.2025.109072_bb0010","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/sj.jhh.1000805","article-title":"Hypertension is associated with a high risk of cancer","volume":"13","author":"Xie","year":"1999","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.bioorg.2025.109072_bb0015","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40959-021-00101-2","article-title":"Etiology and management of hypertension in patients with cancer","volume":"7","author":"Mohammed","year":"2021","journal-title":"Cardio-Oncology"},{"key":"10.1016\/j.bioorg.2025.109072_bb0020","first-page":"238","article-title":"Hypertension in cancer patients and survivors: epidemiology, diagnosis, and management, cardio","volume":"1","author":"Jordana","year":"2019","journal-title":"Oncology"},{"key":"10.1016\/j.bioorg.2025.109072_bb0025","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0002-8703(00)90224-2","article-title":"Efficacy and safety of calcium channel blockers in heart failure: focus on recent trials with second-generation dihydropyridines","volume":"139","author":"de Vries","year":"2000","journal-title":"Am. Heart J."},{"key":"10.1016\/j.bioorg.2025.109072_bb0030","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/pbc.21835","article-title":"Potential chemotherapy side effects: what do oncologists tell parents?","volume":"52","author":"Ramirez","year":"2009","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.bioorg.2025.109072_bb0035","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1007\/s00018-008-8111-5","article-title":"An overview of cancer multidrug resistance: a still unsolved problem","volume":"65","author":"Lage","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bioorg.2025.109072_bb0040","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ejps.2005.10.010","article-title":"The power of the pump: mechanisms of action of P-glycoprotein (ABCB1)","volume":"27","author":"Ambudkar","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2025.109072_bb0045","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1177\/38.9.1974900","article-title":"Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues","volume":"38","author":"Cordon-Cardo","year":"1990","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.bioorg.2025.109072_bb0050","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1124\/dmd.113.056176","article-title":"Inhibition of the multidrug resistance P-glycoprotein: time for a change of strategy?","volume":"42","author":"Callaghan","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bioorg.2025.109072_bb0055","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1634\/theoncologist.8-5-411","article-title":"The role of ABC transporters in clinical practice","volume":"8","author":"Leonard","year":"2003","journal-title":"Oncologist"},{"key":"10.1016\/j.bioorg.2025.109072_bb0060","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/bph.12240","article-title":"Calcium channel blockers and dementia","volume":"169","author":"Nimmrich","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.109072_bb0065","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1474-4422(10)70066-1","article-title":"Effects of \u03b2 blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke","volume":"9","author":"Rothwell","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bioorg.2025.109072_bb0070","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1002\/ange.202011793","article-title":"Structural basis of the modulation of the voltage-gated calcium ion channel Cav1.1 by dihydropyridine compounds","volume":"133","author":"Gao","year":"2021","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2025.109072_bb0075","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature19321","article-title":"Structure of the voltage-gated calcium channel Cav1.1 at 3.6 \u00c5 resolution","volume":"537","author":"Wu","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2025.109072_bb0080","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1126\/science.aad2395","article-title":"Structure of the voltage-gated calcium channel Cav1.1 complex","volume":"350","author":"Wu","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2025.109072_bb0085","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1126\/science.1654596","article-title":"Functional subunit structure of voltage-gated calcium channels","volume":"253","author":"Catterall","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2025.109072_bb0090","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/0166-2236(93)90193-P","article-title":"Structure and function of voltage-gated ion channels","volume":"16","author":"Catterall","year":"1993","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bioorg.2025.109072_bb0095","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ejphar.2019.04.002","article-title":"Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents","volume":"852","author":"Qian","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.109072_bb0100","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.drup.2012.02.002","article-title":"Targeting MDR in breast and lung cancer: discriminating its potential importance from the failure of drug resistance reversal studies","volume":"15","author":"Amiri-Kordestani","year":"2012","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.bioorg.2025.109072_bb0105","doi-asserted-by":"crossref","DOI":"10.1586\/14737140.7.4.447","article-title":"Tariquidar (XR9576): A P-glycoprotein drug efflux pump inhibitor","author":"Fox","year":"2007","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.bioorg.2025.109072_bb0110","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1124\/dmd.115.067785","article-title":"Tariquidar is an inhibitor and not a substrate of human and mouse P-glycoprotein","volume":"44","author":"Weidner","year":"2016","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bioorg.2025.109072_bb0115","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1021\/acs.jmedchem.7b01457","article-title":"Inhibit or evade multidrug resistance P-glycoprotein in cancer treatment: Miniperspective","volume":"61","author":"Waghray","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109072_bb0120","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1747-0285.2010.01025.x","article-title":"Dihydropyridines and multidrug resistance: previous attempts, present state, and future trends","volume":"76","author":"Zarrin","year":"2010","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2025.109072_bb0125","doi-asserted-by":"crossref","first-page":"949","DOI":"10.2174\/138945006778019336","article-title":"Cancer cell permeability-glycoprotein as a target of MDR reverters: possible role of novel dihydropyridine derivatives","volume":"7","author":"Fusi","year":"2006","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.bioorg.2025.109072_bb0130","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ejphar.2014.10.058","article-title":"Cytotoxic and multidrug resistance reversal activities of novel 1,4-dihydropyridines against human cancer cells","volume":"746","author":"Shekari","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.109072_bb0135","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.bmc.2012.10.041","article-title":"Development of small-molecule P-gp inhibitors of the N-benzyl 1,4-dihydropyridine type: novel aspects in SAR and bioanalytical evaluation of multidrug resistance (MDR) reversal properties","volume":"21","author":"Baumert","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109072_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103156","article-title":"Synthesis, in silico and in vitro studies of new 1,4-dihydropiridine derivatives for antitumor and P-glycoprotein inhibitory activity","volume":"91","author":"Mollazadeh","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109072_bb0145","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1080\/07391102.2020.1780942","article-title":"Theoretical studies on 1,4-dihydropyridine derivatives as P-glycoprotein allosteric inhibitors: insights on symmetry and stereochemistry","volume":"39","author":"Mollazadeh","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2025.109072_bb0150","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.canlet.2015.01.006","article-title":"Gelatinases-stimuli nanoparticles encapsulating 5-fluorouridine and 5-aza-2\u2032-deoxycytidine enhance the sensitivity of gastric cancer cells to chemical therapeutics","volume":"363","author":"Wu","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioorg.2025.109072_bb0155","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1159\/000485955","article-title":"Strengthening gastric cancer therapy by trastuzumab-conjugated nanoparticles with simultaneous encapsulation of anti-MiR-21 and 5-fluorouridine","volume":"44","author":"Hu","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.bioorg.2025.109072_bb0160","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ijpharm.2005.08.013","article-title":"Photoprotection of 1,4-dihydropyridine derivatives by dyes","volume":"304","author":"Mielcarek","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioorg.2025.109072_bb0165","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1751-1097.1965.tb09770.x","article-title":"Photochemistry of 5-fluorouracil analogues, glycosides and poly-fu*","volume":"4","author":"Fikus","year":"1965","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.bioorg.2025.109072_bb0170","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2025.109072_bb0175","first-page":"1","article-title":"Am\u00edlcar Celta Falcao, in vitro and in vivo relevance of the P-glycoprotein probe substrates in drug discovery and development: focus on rhodamine 123, digoxin and Talinolol","volume":"01","author":"Ana","year":"2011","journal-title":"J. Bioequiv. Availab."},{"key":"10.1016\/j.bioorg.2025.109072_bb0180","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22903","article-title":"Synthesis, molecular docking, DFT study, and in vitro antimicrobial activity of some 4-(biphenyl-4-yl)-1,4-dihydropyridine and 4-(biphenyl-4-yl)pyridine derivatives","volume":"35","author":"Malani","year":"2021","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.bioorg.2025.109072_bb0185","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1752-153X-7-76","article-title":"Synthesis, insecticidal, and antibacterial activities of novel neonicotinoid analogs with dihydropyridine","volume":"7","author":"He","year":"2013","journal-title":"Chem. Cent. J."},{"key":"10.1016\/j.bioorg.2025.109072_bb0190","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.874709","article-title":"1,4-dihydropyridine as a promising scaffold for novel antimicrobials against helicobacter pylori","volume":"13","author":"Gonz\u00e1lez","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bioorg.2025.109072_bb0195","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.saa.2012.12.069","article-title":"Synthesis, antibacterial and antifungal evaluation of novel 1,4-dihydropyridine derivatives","volume":"113","author":"Abu-Melha","year":"2013","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.bioorg.2025.109072_bb0200","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1135\/cccc19803217","article-title":"Preparation, antibacterial effects and enzymatic degradation of 5-fluorouracil nucleosides","volume":"45","author":"Schwarz","year":"1980","journal-title":"Collect. Czechoslov. Chem. Commun."},{"key":"10.1016\/j.bioorg.2025.109072_bb0205","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.chembiol.2014.11.006","article-title":"The complex mechanism of antimycobacterial action of 5-fluorouracil","volume":"22","author":"Singh","year":"2015","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bioorg.2025.109072_bb0210","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3390\/antibiotics13060528","article-title":"Deciphering the antibacterial mechanisms of 5-fluorouracil in escherichia coli through biochemical and transcriptomic analyses","volume":"13","author":"Zhang","year":"2024","journal-title":"Antibiotics"},{"key":"10.1016\/j.bioorg.2025.109072_bb0215","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.3390\/molecules30132735","article-title":"Antifungal activity of 5-fluorouridine against candida albicans and candida parapsilosis based on virulence reduction","volume":"30","author":"Lenarczyk","year":"2025","journal-title":"Molecules"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825009526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825009526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T02:27:25Z","timestamp":1762223245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825009526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":43,"alternative-id":["S0045206825009526"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109072","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel dihydropyridines as potential calcium-channel and P-glycoprotein blockers applicable for chemotherapy sensitization","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109072"}}